NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ” or “ Evome ”) (TSXV: EVMT) is providing an update to shareholders today. As important background: Evome generates revenue from three main revenue lines: “ DaMar ”. This a business-to-business revenue line. Located in California, DaMar Plastics Manufacturing, Inc. (“ DaMar ”) offers contract manufacturing to a highly concentrated... Read More

NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ”) (TSXV: EVMT) ‎announces the appointment of Michael Dalsin as Chairman of the Board of Directors. Kenneth Kashkin, MD will take the role of Vice-Chairman. Bill Garbarini will retain his role as COO while stepping off the Board of Directors. Chris Heath was also appointed as a new Director increasing the size of the Board of... Read More

SHIRLEY, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ”) (TSXV: EVMT) issued a press release on Monday, February 10, 2025 announcing the details of an amendment (the “ Amendment ”) to the forbearance agreement dated August 4, 2023 between ‎the Company, Biodex Rehab Systems, LLC (“ Biodex Rehab ”), a wholly owned subsidiary of the Company, and ‎Biodex Medical Systems, Inc. (“ Biodex... Read More

SHIRLEY, N.Y., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ”) (TSXV: EVMT) has announced a significant reduction in its overall ‎debt, strengthening its financial position, as a result of the execution of an amendment (the “ Amendment ”) to the forbearance agreement dated August 4, 2023 between the Company, Biodex Rehab Systems, LLC (“ Biodex Rehab ”), a wholly owned subsidiary of the... Read More

SHIRLEY, N.Y., Jan. 20, 2025 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ”) (TSXV: EVMT) is pleased to announce that the Company’s Board of Directors has approved the grant of 1,000,000 restricted stock units (RSUs) to William Garbarini in connection with his appointment as Chief Operating Officer, effective November 22, 2024. The RSUs were granted under the Company’s Amended and Restated 2023 Equity... Read More

SHIRLEY, N.Y., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Shirley, New York, November 25, 2024 – Evome Medical Technologies Inc. (the “ Company ”) (TSXV: EVMT) today reported financial results for the third quarter ended September 30, 2024‎. Among other financial highlights, the Company generated $424,000 in positive Adjusted EBITDA 1 for the quarter on stable revenue. The Company's financial statements for the three and nine months... Read More

SHIRLEY, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ” or “ Evome ”) (TSXV: EVMT) today announced ‎the results from its annual general and special meeting of shareholders held on November 8, 2024 (the ‎‎“ Meeting ”) in Shirley, New York. The total number of shares represented in person or by proxy at the Meeting was ‎‎‎18,991,213‎, representing 31.2% of the total issued and... Read More

Posts updated corporate presentation to website Reminder: Conference call to be held on August 19 th to discuss Q2 2024 financial results SHIRLEY, N.Y., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ” or “ Evome ”) (TSXV: EVMT) highlights its low-CapEx plan for growing revenue in an updated corporate presentation now available at www.evomemedical.com/investor . The presentation, to be used... Read More

Stabilizes business with a return to positive Adjusted EBITDA Promotes Gordon Bean to Chief Financial Officer Announces August 19 th conference call to discuss financial results SHIRLEY, N.Y., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. ‎(the “ Company ” or “ Evome ”) (TSXV: EVMT) today reported financial results for the second quarter ended June 30, 2024, featuring $421,000 in positive Adjusted EBITDA... Read More

NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ” or “ Evome ”) (TSXV: EVMT) is pleased to announce it has entered into an agreement (" Agreement ") with IR Labs Inc. (" irlabs ") to provide the Company with investor relations and communications services. “We look forward to this partnership with irlabs as we work to raise our profile in the investment community,” said Mike Seckler,... Read More

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ” or “ Evome ”) (TSXV: EVMT) announces it has received conditional approval from the TSX Venture Exchange (the “ TSXV ”) to complete a shares for services transaction with Beacon Securities Limited (“ Beacon ”) pursuant to ‎which the Company will issue Beacon ‎504,286 ‎common ‎shares of the Company at a deemed price of ‎$0.1983 per... Read More

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ” or “ Evome ”) (TSXV: EVMT) today provided details on preliminary estimated revenues and margins from April and May 2024, the first two months of the second quarter. Mike Seckler, Chief Executive Officer of the Company, will also hold a call to update shareholders on the first quarter financials, second quarter progress and future... Read More

NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ” or “ Evome ”) (TSXV: EVMT) today reported continued progress on its turn-around plan. Evome has grown revenue at its core business unit, Biodex Medical Systems, Inc. (“ Biodex ”), while reducing total debt significantly for the third straight quarter. The Company announced it generated 100% revenue growth in its Biodex business unit... Read More

NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc (the “ Company ” or “ Evome ”) highlighted the strengthening credit relationship with Pathward, N.A. (“ Pathward ”), the Company’s senior lender. As the Company works to sell non-core business units to reduce acquisition debt in an effort to improve operational profitability, Pathward provides working capital to fuel revenue growth of the Company’s... Read More

NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ” or “ Evome ”) (TSXV: EVMT) has reached an agreement with EB Sports Corp. (the “ Buyer ”)‎, the parent company of Riddell Sports Group, an industry leader in football helmet technology and innovation, to sell Simbex LLC (“ Simbex ”), the Company’s R&D business unit, for approximately $4.83M in cash. The proceeds will be used to pay... Read More

NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ” or “ Evome ”) announced today preliminary annual financial results for the year ending December 31, 2023. Because of a strong fourth quarter, the Company generated positive Adjusted EBITDA for 2023. Summary of Preliminary Annual Financial Results for 2023 Generated annual revenues of $62.6 million Generated annual gross margin of... Read More

NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ” or “ Evome ”) (TSXV: EVMT), is pleased to announce that it has engaged the services of ICP Securities Inc. (" ICP ") to provide automated market making services, including use of its proprietary algorithm, ICP Premium™, for its shares traded on the TSX Venture Exchange (the “ TSXV ”), in compliance with the policies of the TSXV and... Read More

NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ” or “ Evome ”) announces the appointment of two senior healthcare executives to its Board of Directors.‎ Mr. Wayne Anderson, former President and CEO of Ferring Pharmaceuticals USA, has joined as a non-executive ‎member of the Board of Directors.‎ Mr. Bill Garbarini, a former Ferring Pharmaceuticals USA executive and current COO of... Read More

NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “ Company ” or “ Evome ”) has executed a non-binding letter of intent (LOI) to extend acquisition debt of US$3,294,440 to the sellers of Simbex, LLC (“ Simbex ”) to June 30, 2025. In exchange for the extensions, the Company intends to grant the Simbex sellers (i) a subordinated security interest in all non-Biodex assets, (ii) a 10% annual... Read More

NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the ‎‎‎“ Company ”) ‎‎‎(TSXV: EVMT) announced it has reduced acquisition bank debt by $535,093 as a result of the sale of Arrowhead Medical, LLC (“ Arrowhead ”), originally acquired in May 2023 (see News Release dated May 16, 2023). As part of the adjustment, Arrowhead will continue to serve as the exclusive distributor of Biodex products in the... Read More

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the ‎‎‎“ Company ”) ‎‎(TSXV:SGMD), is pleased to announce its corporate name change to Evome Medical Technologies Inc. on January 22, 2024, and trading of the Company's common shares on the TSX Venture Exchange will commence under the ticker symbol "EVMT" on January 22, 2024. The name change reflects the Company’s commitment as a high-tech... Read More

NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the ‎‎‎“ Company ”) ‎‎(TSXV:SGMD), announced today it has executed an exclusive distribution agreement with Veteran Medical Solutions, LLC (“ VMS ”), a U.S. military veteran owned company that is positioned to sell the Company’s Biodex branded equipment. The Veterans Health Administration of the U.S. Department of Veterans Affairs is the... Read More

NEW YORK, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the ‎‎‎“ Company ”) (TSXV:SGMD), announced today the debut of the Biodex Reactive Step Trainer (“ RST ”): A revolutionary medical device that combines Biodex Rehab’s industry leading gait trainer platform with a clinically proven perturbation training system. There is a critical need for a proactive approach to fall prevention as the... Read More

NEW YORK, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the ‎‎‎“ Company ”) (TSXV:SGMD), soon to be renamed Evome Medical Technologies Inc., today announced the debut of the Biodex SpaceTek Knee™ Device: A revolutionary, portable medical device for treating patients with knee replacements and knee injuries. Approximately 790,000 total knee replacements are performed annually in the United... Read More

NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the ‎‎“ Company ”) (TSXV:SGMD), soon to be renamed Evome Medical Technologies Inc., today announced financial highlights for its third quarter, ending September 30, 2023. Financial Headlines Revenues Generated $19,647,489 in revenue for the quarter ending September 30, 2023. 18.5% increase from the previous quarter. 78.3% increase from the... Read More

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the ‎‎‎“ Company ”) (TSXV:SGMD), soon to be renamed Evome Medical Technologies Inc., announced its attendance at Medica 2023 which is held annually in Dusseldorf, Germany. Being one of the premier events in the medical industry around the globe it allows the Company to showcase its products to the industry professionals and connect with... Read More

NEW YORK, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device ‎Corporation (the ‎‎“ Company ”) (TSXV:SGMD) today announced it has booked a $837,000 order for its Biodex System Pro4™ and Biodex ‎System 4 MVP™ Isokinetic dynamometer machines from its international distributor in Poland ‎which represents an increase of 157% in revenues over 2022 for that market. This order follows the Company’s recent announcement... Read More

NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device ‎Corporation (the ‎‎“ Company ”) (TSXV:SGMD) today ‎announced ‎its intention to change its name to “Evome Medical Technologies Inc.” subject to governmental and regulatory approvals. The proposed name change reflects the direction the new management team is taking toward higher margin recovery science products and services to advance organic growth and... Read More

NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“ Salona Global ”, “ SGMD ” or the ‎‎“ Company ”) (TSXV:SGMD) today announced the expansion of its bank line. On September 12, 2023, an operating subsidiary of the Company, Biodex Medical Systems, Inc. (the “ Borrower ”), entered into a Master Credit and Security Agreement and related Schedule (the " Agreement ") with Pathward, National... Read More

NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“ Salona Global ” or the ‎‎“ Company ”) (TSXV:SGMD) today posted financial results for the second quarter of 2023, ending June 30, 2023, and provided an update on its turn-around plan. During the second quarter, the Company acquired Biodex Medical Systems, Inc. (“ Biodex ”), pushing revenue to $16.6 million for the three months ended June... Read More

NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “ Company ”) (TSXV:SGMD) today announced it has executed an agreement (the “ Agreement ”) to extend the payment terms of the debt incurred in connection with its acquisition of Biodex Medical Systems, Inc. (“ Biodex ”). On April 3, 2023, the Company acquired all of the outstanding equity of Biodex in consideration for, among other... Read More

NEW YORK, July 25, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“ SGMD ”, “ Salona Global ” or ‎the “ Company ”) (TSXV:SGMD) today announced a 15% debt reduction as part of a restructuring effort with the seller of Biodex Medical Systems, Inc. (“ Biodex ”) and provided an update on costs cuts and other debt restructuring plans. Additionally, the Company announced Mr. Mike Seckler has moved from interim... Read More

SAN DIEGO, Calif., June 14, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“ SGMD ”, “ Salona Global ” or the “ Company ”) (TSXV:SGMD) is pleased to announce the appointment of Michael Seckler as interim CEO, effective June 13, 2023. Mr. Seckler has a long and successful track record as a senior executive of Ferring Pharmaceuticals, a multi-billion dollar company based in Switzerland, where he was the... Read More

SAN DIEGO, May 25, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“ Salona Global ”, “ SGMD ” or the ‎‎“ Company ”) (TSXV:SGMD) is pleased to announce the appointment of Lana Newishy to its Board of Directors as Executive Vice Chair, effective May 24, 2023. Ms. Newishy is the former CFO of American Express Corporate Card Canada and most recently served as a senior executive in the Chief of Staff Office... Read More

SAN DIEGO, May 16, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“ Salona Global ”, “ SGMD ” or the ‎‎“ Company ”) (TSXV:SGMD) today announced it closed its acquisition of Arrowhead Medical, LLC ( “Arrowhead” ), a recovery science medical device sales and distribution business expected to add $4.0 million in annual revenue to the Company, with an estimated 32% in gross profit. The Company also reported... Read More

SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (TSXV:SGMD) announced that it will hold an earnings conference call (see details below) to discuss its first quarter 2023 financial results, including details on organic growth for the quarter, deal flow, and acquisition integration status, on Tuesday, May 16, 2023 at 5:00 pm (Eastern Time) and will issue an earnings press release earlier... Read More

SAN DIEGO, April 03, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“ Salona Global ”, “ SGMD ” or the ‎‎“ Company ”) (TSXV:SGMD) today announced it has closed the acquisition of all of the capital stock of Biodex Medical Systems, Inc., which consists principally of the Biodex Physical Medicine (Rehabilitation) business (“ Biodex ”), expected to add $26 million in annual revenue to the Company, with an... Read More

SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“ Salona Global ,” “ SGMD ,” or the ‎‎“ Company ”) (TSXV:SGMD) announced that it executed a stock purchase agreement (the “Agreement” ) to purchase all of the shares of capital stock of Biodex Medical Systems, Inc. ( “Biodex” ), which consists principally of the Biodex Physical Medicine (Rehabilitation) business (the “Acquisition” ). The... Read More

SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“ Salona Global ,” “ SGMD ,” or the ‎‎“ Company ”) (TSXV:SGMD) today provided an update to its acquisition plans and pipeline. The Company is also publishing an up-to-date presentation for upcoming meetings with U.S. institutional investors. In addition to the pending acquisition of Biodex Medical Systems, Inc. (“ Biodex ”), previously... Read More

SAN DIEGO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“ Salona Global ”, “ SGMD ” or the ‎‎“ Company ”) (TSXV:SGMD) today announced highlights for the third fiscal quarter of 2023, ending November 30, 2022. The Company posted 211% year-over-year revenue growth, 231% year-over-year gross margin growth, and improved gross margin as a percentage of revenue by 10% over last quarter to 33%. The... Read More

SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (TSXV:SGMD) announced that it will hold an earnings conference call (see details below) to discuss its third quarter 2022 financial results, including details on organic growth for the quarter, deal flow, and acquisition status, on Tuesday, January 17, 2023 at 5:00 pm (Eastern Time) and will issue an earnings press release earlier that... Read More

SAN DIEGO, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“ Salona Global ”, “ SGMD ”, or the “ Company ”) (TSXV:SGMD) announced today its intention to focus on listing on the Nasdaq Capital Market (“ Nasdaq ”) in 2023. As a first step, Salona Global has changed its fiscal year end to December 31, 2022 with the aim of preparing for a U.S. listing, and has withdrawn the recently announced... Read More